Loading insider details...
Beta
Latest Form 4 (Jun 10, 2026): Exercise/Conversion of 8,700 COLL shares, $143.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Exercise/Conversion | 8,700 | $143.5K |
| May 29, 2026 | COMPASS Pathways plc (CMPS) | Grant/Award | 30,158 | n/a |
| May 18, 2026 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 8,741 | n/a |
| Aug 19, 2025 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Exercise/Conversion | 15,000 | $201.8K |
| Jun 13, 2025 | COMPASS Pathways plc (CMPS) | Grant/Award | 39,000 | n/a |
| May 19, 2025 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 9,791 | n/a |
| Sep 4, 2024 | COMPASS Pathways plc (CMPS) | Grant/Award | 52,000 | n/a |
| May 16, 2024 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 7,693 | n/a |
| May 19, 2023 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 9,792 | n/a |
| May 23, 2022 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 14,035 | n/a |